Dose escalation in prostate cancer with IMRT (76 GY-80 GY).: Acute and late toxicity.

被引：0
|
作者：
Torrecilla, A. Lopez
Rosello, J.
Pastor, J.
Miragall, E. Garcia
Planas, D.
Hernandez, A.
机构：
[1] Hosp Gen Univ, Valencia, Spain
[2] Hosp Gen Univ, Valencia, Spain
[3] Hosp Gen Univ, Valencia, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] IMRT from 70 Gy to 80 Gy in prostate cancer: clinical and dosimetric predictors of late toxicity
    Jolnerosvki, M.
    Salleron, J.
    Beckendorf, V.
    Peiffert, D.
    Baumann, A. S.
    Bernier-Chastagner, V.
    Marchesi, V.
    Huger, S.
    Vogin, G.
    Chira, C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S638 - S638
  • [2] Toxicity Analysis of Dose Escalation From 75.6 Gy to 81.0 Gy in Prostate Cancer
    Xu, Natalie
    Rossi, Peter J.
    Jani, Ashesh B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 11 - 15
  • [3] Dose Escalation in Prostate Radiotherapy up to 82 Gy Using Simultaneous Integrated Boost Direct Comparison of Acute and Late Toxicity with 3D-CRT 74 Gy and IMRT 78 Gy
    Dolezel, Martin
    Odrazka, Karel
    Vaculikova, Miloslava
    Vanasek, Jaroslav
    Sefrova, Jana
    Paluska, Petr
    Zouhar, Milan
    Jansa, Jan
    Macingova, Zuzana
    Jarosova, Lida
    Brodak, Milos
    Moravek, Petr
    Hartmann, Igor
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (04) : 197 - 202
  • [4] Acute and Late toxicity of Dose-escalation Intensity Modulated Arc Therapy (RapidArc) for Prostate cancer to 82.8 Gy: an Update
    Hentschel, B.
    Strauss, D.
    Wagner, K.
    Dorn, U.
    Oehler, W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 72 - 72
  • [5] Late toxicity in the GETUG 116 randomized trial comparing 70 Gy and 80 Gy for localized prostate cancer
    Beckendorf, V.
    Guerif, S.
    Le Prise, E.
    Cossett, J. M.
    Le Floch, O.
    Chauvet, B.
    Salem, N.
    Chapet, O.
    Bourdin, S.
    Bey, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S319 - S319
  • [6] 78 Gy prostrate cancer dose escalation programme: dosimetry and acute toxicity
    Bell, M.
    Joon, D. Lim
    Khoo, V.
    Mantle, C.
    Chee, R.
    Zupain, E.
    Spiteri, L.
    See, A.
    Joon, M. Lim
    Rykers, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 297 - 298
  • [7] DOSE ESCALATION WITH HYPOFRACTIONATED IMRT FOR PROSTATE CANCER: ACUTE TOXICITY
    Zilli, T.
    Molla, M.
    Rouzaud, M.
    Nouet, P.
    Wang, H.
    Dipasquale, G.
    Escude, L.
    Casanova, N.
    Linero, D.
    Miralbell, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (11) : 625 - 625
  • [8] ARE THE DOSE ESCALATION TO MORE THEN 70 GY CAUSES INCREASED ACUTE AND LATE RECTAL AND BLADDER TOXICITY?
    Urbanczyk, H.
    Ciechowicz, J.
    Miszczyk, L.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S313 - S313
  • [9] 70 gy versus (vs) 80 gy dose escalation Getug 06 French trial for localized prostate cancer: Mature results
    Beckendorf, V.
    Guerif, S.
    Le Prise, E.
    Cosset, J.
    Bougnoux, A.
    Chauvet, B.
    Salem, N.
    Romestaing, P.
    Luporsi, E.
    Bey, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S96 - S97
  • [10] The getug 70 GY vs. 80 GY randomized trial for localized prostate cancer:: Feasibility and acute toxicity
    Beckendorf, V
    Guérif, S
    Le Prisé, E
    Cosset, JM
    Lefloch, O
    Chauvet, B
    Salem, N
    Chapet, O
    Bourdin, S
    Bachaud, JM
    Maingon, P
    Lagrange, JL
    Malissard, L
    Simon, JM
    Pommier, P
    Hay, MH
    Dubray, B
    Luporsi, E
    Bey, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04): : 1056 - 1065
12345